Dyspnea

The American College of Cardiology recently issued an expert consensus document outlining a novel staging system and decision pathway for the diagnosis, treatment and longitudinal follow-up of patients with myocarditis.

Close to 40% of Hispanic men employed as engineered stone countertop workers with silicosis had an atypical pattern of the disease on CT imaging, according to research presented at the Radiological Society of North America Annual Meeting.

BOSTON — Lung function, symptoms and quality of life improved with receipt of ensifentrine in both adults with moderate COPD and adults with severe COPD, according to data presented at the CHEST Annual Meeting.

BOSTON — Fatigue and shortness of breath among patients with idiopathic pulmonary fibrosis got worse after being hospitalized, according to data presented at the CHEST Annual Meeting.

In young adults with normal spirometry, e-cigarette users and tobacco smokers had similar poorer exercise capacity vs. never vapers/smokers, according to a presentation at the European Respiratory Society International Congress.

The FDA approved axatilimab-csfr for certain patients with chronic graft-versus-host disease.

A 15-day course of Paxlovid demonstrated no significant benefit for patients with post-acute sequelae of SARS-CoV-2 infection, according to data published in JAMA Internal Medicine.

SAN DIEGO — Individuals with inspiratory muscle weakness 2 years after COVID-19 hospitalization had improvement with inspiratory muscle training, according to research presented at the American Thoracic Society International Conference.

SAN DIEGO — Among patients with moderate to severe COPD, 24-week ensifentrine improved dyspnea, according to research presented at the American Thoracic Society International Conference.

LONG BEACH, Calif. — Hydralazine-induced autoimmune conditions may have a varied presentation, including drug-induced lupus or vasculitis, according to a speaker, here.